|
Delayed
Australian S.E.
04:30:05 29/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0100 AUD | 0.00% |
|
0.00% | -33.33% |
| 12/10 | Acrux Limited - Shareholder/Analyst Call | |
| 26/08 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 41.47L | - | - | - | - | - |
| 1,14300Cr | |||||
| 65TCr | |||||
| 51TCr | |||||
| 38TCr | |||||
| 35TCr |
- Stock Market
- Stocks
- ACR Stock
- Charts Acrux Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
